Literature DB >> 27400908

Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis.

Danielle F Wurzel1, Julie M Marchant2, Stephanie T Yerkovich3, John W Upham4, Helen L Petsky2, Heidi Smith-Vaughan5, Brent Masters2, Helen Buntain6, Anne B Chang7.   

Abstract

BACKGROUND: Protracted bacterial bronchitis (PBB) and bronchiectasis are distinct diagnostic entities that share common clinical and laboratory features. It is postulated, but remains unproved, that PBB precedes a diagnosis of bronchiectasis in a subgroup of children. In a cohort of children with PBB, our objectives were to (1) determine the medium-term risk of bronchiectasis and (2) identify risk factors for bronchiectasis and recurrent episodes of PBB.
METHODS: One hundred sixty-one children with PBB and 25 control subjects were prospectively recruited to this cohort study. A subset of 106 children was followed for 2 years. Flexible bronchoscopy, BAL, and basic immune function tests were performed. Chest CT was undertaken if clinical features were suggestive of bronchiectasis.
RESULTS: Of 161 children with PBB (66% boys), 13 were diagnosed with bronchiectasis over the study period (8.1%). Almost one-half with PBB (43.5%) had recurrent episodes (> 3/y). Major risk factors for bronchiectasis included lower airway infection with Haemophilus influenzae (recovered in BAL fluid) (P = .013) and recurrent episodes of PBB (P = .003). H influenzae infection conferred a more than seven times higher risk of bronchiectasis (hazard ratio, 7.55; 95% CI, 1.66-34.28; P = .009) compared with no H influenzae infection. The majority of isolates (82%) were nontypeable H influenzae. No risk factors for recurrent PBB were identified.
CONCLUSIONS: PBB is associated with a future diagnosis of bronchiectasis in a subgroup of children. Lower airway infection with H influenzae and recurrent PBB are significant predictors. Clinicians should be cognizant of the relationship between PBB and bronchiectasis, and appropriate follow-up measures should be taken in those with risk factors.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bacterial infection; bronchiectasis; pediatric lung disease; respiratory infection; viral infection

Mesh:

Year:  2016        PMID: 27400908     DOI: 10.1016/j.chest.2016.06.030

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

1.  The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trial.

Authors:  Kerry-Ann F O'Grady; Anne B Chang; Allan Cripps; Edward K Mulholland; Heidi Smith-Vaughan; Nicholas Wood; Margaret Danchin; Ruth Thornton; Andrew Wilson; Paul J Torzillo; Peter M Morris; Peter Richmond; Sheree Rablin; Daniel Arnold; Ann Connor; Vikas Goyal; Tanya Stoney; Kirsten Perrett; Keith Grimwood
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

2.  Phenotypic presentation of chronic cough in children.

Authors:  Ahmad Kantar
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

3.  Childhood 'bronchitis' and respiratory outcomes in middle-age: a prospective cohort study from age 7 to 53 years.

Authors:  Jennifer L Perret; Danielle Wurzel; E Haydn Walters; Adrian J Lowe; Caroline J Lodge; Dinh S Bui; Bircan Erbas; Gayan Bowatte; Melissa A Russell; Bruce R Thompson; Lyle Gurrin; Paul S Thomas; Garun Hamilton; John L Hopper; Michael J Abramson; Anne B Chang; Shyamali C Dharmage
Journal:  BMJ Open Respir Res       Date:  2022-06

4.  ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.

Authors:  Alyn H Morice; Eva Millqvist; Kristina Bieksiene; Surinder S Birring; Peter Dicpinigaitis; Christian Domingo Ribas; Michele Hilton Boon; Ahmad Kantar; Kefang Lai; Lorcan McGarvey; David Rigau; Imran Satia; Jacky Smith; Woo-Jung Song; Thomy Tonia; Jan W K van den Berg; Mirjam J G van Manen; Angela Zacharasiewicz
Journal:  Eur Respir J       Date:  2020-01-02       Impact factor: 16.671

Review 5.  ERS statement on protracted bacterial bronchitis in children.

Authors:  Ahmad Kantar; Anne B Chang; Mike D Shields; Julie M Marchant; Keith Grimwood; Jonathan Grigg; Kostas N Priftis; Renato Cutrera; Fabio Midulla; Paul L P Brand; Mark L Everard
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

Review 6.  Antibiotics for prolonged wet cough in children.

Authors:  Julie M Marchant; Helen L Petsky; Peter S Morris; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2018-07-31

7.  Persistent Bacterial Bronchitis: Time to Venture beyond the Umbrella.

Authors:  Andrew Bush
Journal:  Front Pediatr       Date:  2017-12-11       Impact factor: 3.418

8.  Cytokine responses to two common respiratory pathogens in children are dependent on interleukin-1β.

Authors:  Alice C-H Chen; Yang Xi; Melanie Carroll; Helen L Petsky; Samantha J Gardiner; Susan J Pizzutto; Stephanie T Yerkovich; Katherine J Baines; Peter G Gibson; Sandra Hodge; Ian B Masters; Helen M Buntain; Anne B Chang; John W Upham
Journal:  ERJ Open Res       Date:  2017-10-02

9.  Clinical and research priorities for children and young people with bronchiectasis: an international roadmap.

Authors:  Anne B Chang; Jeanette Boyd; Leanne Bell; Vikas Goyal; I Brent Masters; Zena Powell; Christine Wilson; Angela Zacharasiewicz; Efthymia Alexopoulou; Andrew Bush; James D Chalmers; Rebecca Fortescue; Adam T Hill; Bulent Karadag; Fabio Midulla; Gabrielle B McCallum; Deborah Snijders; Woo-Jung Song; Thomy Tonia; Keith Grimwood; Ahmad Kantar
Journal:  ERJ Open Res       Date:  2021-07-19

Review 10.  An underestimated cause of chronic cough: The Protracted Bacterial Bronchitis.

Authors:  Paola Di Filippo; Alessandra Scaparrotta; Marianna Immacolata Petrosino; Marina Attanasi; Sabrina Di Pillo; Francesco Chiarelli; Angelika Mohn
Journal:  Ann Thorac Med       Date:  2018 Jan-Mar       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.